Form D · Biotechnology
Moonlight Therapeutics Inc.
Marietta, GA · CIK 0002033833
Offering snapshot reported Aug 16, 2024 · SEC filing
- Reported sold
- $2.42M Offering amount: $3.35M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 1, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 16, 2024 | Initial | $2,419,000 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-521704
A portion of the Total Amount Sold is from proceeds resulting from the conversion of outstanding convertible securities in the Company
Source: Form D, filed Aug 16, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samirkumar Patel | Director, Executive |
| Ritu Shah | Director |
| Harold Shlevin | Director |
| Vladimir Zarnitsyn | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2785 Stone Hall Dr.
Marietta, GA, 30062
Marietta, GA, 30062